Dunham & Associates Investment Counsel, Inc. Appoints Ryan Dykmans, CFA, as President Amid Continued Firm Growth

Dunham & Associates Investment Counsel, Inc. (“Dunham”) today announced the promotion of Chief Investment Officer Ryan Dykmans, CFA, to President, effective October 1, 2025. This appointment marks an important milestone in the firm's continued growth and leadership. Dykmans, who joined Dunham more than two decades ago as an intern, has steadily risen through the ranks […]

C3.AI INVESTOR NOTICE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead the C3.ai Class Action Lawsuit – RGRD Law

(NYSE:AI), SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai as well as

C3.AI INVESTOR NOTICE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead the C3.ai Class Action Lawsuit – RGRD Law

C3.AI INVESTOR NOTICE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead the C3.ai Class Action Lawsuit – RGRD Law GlobeNewswire September 02, 2025 SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai,

Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical’s Galway and Tecate Facilities

This milestone enhances Quasar's global CDMO platform, broadening end-to-end capabilitiesand providing increased value for medical device OEMs and innovators. Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, today announced the completion of its acquisition of Nordson Corporation's (Nasdaq: NDSN) design & development contract manufacturing businesses in Galway, Ireland, and Tecate,

Bronstein, Gewirtz & Grossman, LLC Is Investigating C3.ai, Inc. (AI) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / September 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of C3.ai, Inc. ("C3.ai" or "the Company") (NYSE:AI). Investors who purchased C3.ai securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AI. Investigation

Etude Capital Acquires 9-Property Storage Portfolio

Etude Capital announced today the acquisition of nine self-storage properties comprising over 800,000 netrentable square feet and more than 6,600 units for an aggregate purchase price of approximately $166 million. The properties were acquired from a single seller and are located in Northern and Southern California and Las Vegas, Nevada. The properties will be managed

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / September 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to

Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

Extreme Networks, Inc. (EXTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / September 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to

Scroll to Top